Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials.
Mysler E, Burmester GR, Saffore CD, Liu J, Wegrzyn L, Yang C, Betts KA, Wang Y, Irvine AD, Panaccione R. Mysler E, et al. Among authors: irvine ad. Adv Ther. 2024 Feb;41(2):567-597. doi: 10.1007/s12325-023-02732-6. Epub 2024 Jan 2. Adv Ther. 2024. PMID: 38169057 Free PMC article. Review.
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis.
Blauvelt A, Eyerich K, Irvine AD, de Bruin-Weller M, Kwatra SG, Gooderham M, Kim B, Calimlim BM, Lee WJ, Raymundo EM, Liu Y, Ofori S, Platt AM, Silverberg JI. Blauvelt A, et al. Among authors: irvine ad. Dermatol Ther (Heidelb). 2024 Sep;14(9):2621-2630. doi: 10.1007/s13555-024-01242-9. Epub 2024 Aug 7. Dermatol Ther (Heidelb). 2024. PMID: 39110139 Free PMC article.
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.
Paller AS, Mendes-Bastos P, Siegfried E, Eichenfield LF, Soong W, Prajapati VH, Lio P, Simpson EL, Raymundo EM, Suravaram S, Hu X, Yang Y, Huang X, Calimlim BM, Platt AM, Su JC, Zheng M, Yamamoto-Hanada K, Teixeira HD, Irvine AD. Paller AS, et al. Among authors: irvine ad. JAMA Dermatol. 2024 Oct 23. doi: 10.1001/jamadermatol.2024.3696. Online ahead of print. JAMA Dermatol. 2024. PMID: 39441580
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
Hebert AA, Flohr C, Hong HC, Irvine AD, Pierce E, Elmaraghy H, Pillai S, Dawson Z, Chen S, Armengol C, Siegfried E, Weidinger S. Hebert AA, et al. Among authors: irvine ad. J Dermatolog Treat. 2024 Dec;35(1):2324833. doi: 10.1080/09546634.2024.2324833. Epub 2024 May 12. J Dermatolog Treat. 2024. PMID: 38735650 Free article. Clinical Trial.
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).
Irvine AD, Jones AP, Beattie P, Baron S, Browne F, Ashoor F, O'Neill L, Rosala-Hallas A, Sach T, Spowart C, Taams L, Walker C, Wan M, Webb N, Williamson P, Flohr C; TREAT Trial Investigators. Irvine AD, et al. Br J Dermatol. 2018 Dec;179(6):1297-1306. doi: 10.1111/bjd.16717. Epub 2018 Oct 28. Br J Dermatol. 2018. PMID: 29727479
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.
Haag C, Alexis A, Aoki V, Bissonnette R, Blauvelt A, Chovatiya R, Cork MJ, Danby SG, Eichenfield L, Eyerich K, Gooderham M, Guttman-Yassky E, Hijnen DJ, Irvine A, Katoh N, Murrell DF, Leshem YA, Levin A, Vittrup I, Olydam JI, Orfali RL, Paller A, Renert-Yuval Y, Rosmarin D, Silverberg J, Thyssen J, Ständer S, Stefanovic N, Todd G, Yu J, Simpson E. Haag C, et al. Br J Dermatol. 2024 Sep 10:ljae342. doi: 10.1093/bjd/ljae342. Online ahead of print. Br J Dermatol. 2024. PMID: 39250758 Free article.
A patient's experience of progressive hemifacial atrophy.
Larney C, Watson R, Murray D, Irvine AD. Larney C, et al. Among authors: irvine ad. Clin Exp Dermatol. 2024 Jul 6:llae255. doi: 10.1093/ced/llae255. Online ahead of print. Clin Exp Dermatol. 2024. PMID: 38970530 No abstract available.
327 results